Yamashiro’s group found that suppression of ATF5 activity with an inhibitory peptide led to a concentration-dependent decrease of cell viability and increase of cell apoptosis in a panel of human neuroblastoma cell lines regardless of MYCN amplification11. This evidence concerns the gene MYCN and neuroblastoma.